Global Point-Of-Care Or Rapid Diagnostics Market Growth 2025-2031

Global Point-Of-Care Or Rapid Diagnostics Market Growth 2025-2031

The global Point-Of-Care Or Rapid Diagnostics market size is predicted to grow from US$ 20650 million in 2025 to US$ 31810 million in 2031; it is expected to grow at a CAGR of 7.5% from 2025 to 2031.

Point-of-care (POC) and Rapid Diagnostic is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

The Point of Care and Rapid Diagnostic market is primarily driven by the rising demand for rapid and accessible diagnostic solutions. This demand is fueled by the need for quicker decision-making in healthcare, especially in remote or resource-constrained settings. Additionally, the increasing prevalence of chronic diseases, such as diabetes and cardiovascular conditions, is propelling the adoption of POCT devices for monitoring and early detection. Moreover, the emphasis on decentralized healthcare and patient-centric approaches is pushing the market to develop more user-friendly and efficient POCT solutions.

While the key challenges facing the POCT product and device market is the necessity for strict regulatory compliance and quality assurance. Ensuring that POCT devices meet regulatory standards and maintain accuracy and reliability is critical for patient safety and effective healthcare delivery. Additionally, challenges related to data management, connectivity, and integration with electronic health records need to be addressed to fully leverage the potential of POCT in improving healthcare outcomes. Balancing ease of use with regulatory compliance remains a pivotal challenge for manufacturers in this rapidly evolving market.

The major global manufacturers of Point of Care and Rapid Diagnostic include Abbott, Roche, Danaher, Siemens Healthineers, QuidelOrtho, LifeScan, Wondfo, BioMerieux, Ascensia, ARKRAY, etc. In 2023, the world's top five vendors accounted for approximately 73.47% of the revenue.

LP Information, Inc. (LPI) ' newest research report, the “Point-Of-Care Or Rapid Diagnostics Industry Forecast” looks at past sales and reviews total world Point-Of-Care Or Rapid Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Point-Of-Care Or Rapid Diagnostics sales for 2025 through 2031. With Point-Of-Care Or Rapid Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Point-Of-Care Or Rapid Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Point-Of-Care Or Rapid Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Point-Of-Care Or Rapid Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Point-Of-Care Or Rapid Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Point-Of-Care Or Rapid Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Point-Of-Care Or Rapid Diagnostics.

This report presents a comprehensive overview, market shares, and growth opportunities of Point-Of-Care Or Rapid Diagnostics market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Urinalysis Testing
Other

Segmentation by Application:
Hospital
Clinic
Independent Laboratories
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche
Abbott
LifeScan
Siemens Healthineers
Danaher
Ascensia
BioMerieux
ARKRAY
Bio-Rad Laboratories
Nova Biomedical
QuidelOrtho
Accriva
OraSure Technologies
Helena Laboratories
Phamatech
Chembio Diagnostics
Trinity Biotech
Wuhan Easy Diagnosis
Intec PRODUCT
Sinocare
Wondfo
Getein Biotech

Key Questions Addressed in this Report

What is the 10-year outlook for the global Point-Of-Care Or Rapid Diagnostics market?

What factors are driving Point-Of-Care Or Rapid Diagnostics market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Point-Of-Care Or Rapid Diagnostics market opportunities vary by end market size?

How does Point-Of-Care Or Rapid Diagnostics break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.